Ranked #1
Methotrexate
Methotrexate
The foundations of #oncopharm series continues with methotrexate. We begin with its origin story and end discussion mod... Read more
4 May 2018
•
22mins
Ranked #2
Foundations in Oncology Pharmacy: Cisplatin
Foundations in Oncology Pharmacy: Cisplatin
The Foundations in Oncology Pharmacy series begins with the penicillin of oncology: cisplatin. Discussion of its histor... Read more
12 Jan 2018
•
14mins
Similar Podcasts
HOPA Now
Plenary Session
The Curbsiders Internal Medicine Podcast
Core IM | Internal Medicine Podcast
JAMA Clinical Reviews
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
The Oncology Nursing Podcast
The Clinical Problem Solvers
Let's Talk ID
EMCrit Podcast - Critical Care and Resuscitation
HypochondriActor
The Cribsiders
Stuff You Should Know
Radiolab
Hidden Brain
Ranked #3
Rituximab
Rituximab
We explore the origins of rituximab's dose, geek out on the NNT in DLBC, and discuss other "need to know" tidbits.
9 Aug 2018
•
18mins
Ranked #4
5-Fluorouracil
5-Fluorouracil
5-FU: both its mechanisms, all its toxicities, most of its uses, and some of its history are discussed.
14 Sep 2018
•
18mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
Paclitaxel
Paclitaxel
We discuss paclitaxel, from its discovery to its uses to toxicity and their management as part of our Landmarks in #Onco... Read more
11 Jul 2018
•
16mins
Ranked #6
Trastuzumab Deruxtecan
Trastuzumab Deruxtecan
Kicking off the 2020 Pod season with the last FDA-approval of 2019 - trastuzumab deruxtecan.
2 Jan 2020
•
13mins
Ranked #7
Vincristine
Vincristine
The Foundations in Oncology Pharmacy continues with vincristine. Its origin, unique toxicity profile, and clinical use ... Read more
6 Apr 2018
•
18mins
Ranked #8
FOLFOX (MOSAIC Trial)
FOLFOX (MOSAIC Trial)
The Landmarks in Oncology Pharmacy series returns with a discussion of MOSAIC: FOLFOX adjuvant chemotherapy for stage ii... Read more
13 Dec 2018
•
20mins
Ranked #9
Carboplatin
Carboplatin
The basic must-know information for carboplatin, for students, residents, or anyone looking for a refresher.
31 Oct 2019
•
20mins
Ranked #10
Foundations in Oncology Pharmacy: Doxorubicin
Foundations in Oncology Pharmacy: Doxorubicin
Overview of doxorubicin from its Italian origins to its Red Devil alias. Uses and toxicities also discussed, of course.
2 Feb 2018
•
15mins
Ranked #11
Cannabidiol (CBD) & Potential Drug Interactions In Cancer Patients
Cannabidiol (CBD) & Potential Drug Interactions In Cancer Patients
CBD use is becoming more widespread in society, including in cancer patients. Potential, and significant, drug interact... Read more
7 Feb 2019
•
14mins
Ranked #12
Updates: Venetoclax use in multiple myeloma, atezolizumab in small cell lung cancer
Updates: Venetoclax use in multiple myeloma, atezolizumab in small cell lung cancer
This week brought several notable updates we discuss: the FDA's concern with a venetoclax clinical trial in multiple mye... Read more
21 Mar 2019
•
13mins
Ranked #13
Mucositis & Stomatitis
Mucositis & Stomatitis
Mucositis & stomatitis are basically interchangeable terms for one of the hallmark chemotherapy toxicities. We disc... Read more
31 Jan 2019
•
19mins
Ranked #14
Irinotecan
Irinotecan
The Foundations of #OncoPharm series returns with all the must-know information for irinotecan.
29 Aug 2019
•
17mins
Ranked #15
Tamoxifen
Tamoxifen
The Foundations in #Oncopharm series returns with the story of a failed contraceptive candidate that became the first (?... Read more
3 Jul 2019
•
20mins
Ranked #16
Enfortumab-vedotin (& Asciminib)
Enfortumab-vedotin (& Asciminib)
Closing out the year discussing FDA's approval of enfortumab-vedotin for urothelial cancer and a new, but pharmacologica... Read more
26 Dec 2019
•
16mins
Ranked #17
Cycling thru the CDK Inhibitors
Cycling thru the CDK Inhibitors
Abemaciclib's up-front approval provides an opportunity to review all 3 currently FDA-approved CDK 4/6 inhibitors. Dosi... Read more
1 Mar 2018
•
18mins
Ranked #18
Rise (& Fall) Of ESAs
Rise (& Fall) Of ESAs
Describing the rationale for and rise in widespread ESA use for cancer patients going back 30 years....and why their use... Read more
21 Nov 2018
•
22mins
Ranked #19
Cyclophosphamide
Cyclophosphamide
Discussing one of the main workhorse #oncopharm agents: cyclophosphamide. Topics include is bioactivation, myriad of us... Read more
15 Nov 2018
•
18mins
Ranked #20
Selinexor
Selinexor
A brief discussion on FDA's approval decision on selinexor and its possible role in therapy. Then, a more in-depth detai... Read more
18 Jul 2019
•
15mins
